{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:38:19Z","timestamp":1773286699527,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1331\/japha.2014.13195","type":"journal-article","created":{"date-parts":[[2014,5,23]],"date-time":"2014-05-23T22:30:56Z","timestamp":1400884256000},"page":"374-382","source":"Crossref","is-referenced-by-count":26,"title":["Prescription medication burden in patients with newly diagnosed diabetes: A SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study"],"prefix":"10.1016","volume":"54","author":[{"given":"Julie A.","family":"Schmittdiel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marsha A.","family":"Raebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Dyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn K.","family":"Goodrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily B.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodi B.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean M.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Lester Kirchner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy J.","family":"Karter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer Elston","family":"Lafata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa G.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1331\/JAPhA.2014.13195_bb0010","unstructured":"Centers for Disease Control and Prevention. National diabetes fact sheet, 2011. www.cdc.gov\/DIABETES\/pubs\/factsheet11.htm. Accessed July 22, 2013."},{"issue":"3","key":"10.1331\/JAPhA.2014.13195_bb0015","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/dc08-9017","article-title":"Economic costs of diabetes in the U.S. in 2007","volume":"31","author":"American Diabetes Association","year":"2008","journal-title":"Diabetes Care"},{"issue":"45","key":"10.1331\/JAPhA.2014.13195_bb0020","first-page":"918","article-title":"Increasing prevalence of diagnosed diabetes\u2014United States and Puerto Rico, 1995\u20132010","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1331\/JAPhA.2014.13195_bb0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1377\/hlthaff.2009.0155","article-title":"The economic burden of diabetes","volume":"29","author":"Dall","year":"2010","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"10.1331\/JAPhA.2014.13195_bb0030","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.diabres.2009.11.021","article-title":"Impact of type 2 diabetes mellitus on prescription medication burden and out-of-pocket healthcare expenses","volume":"87","author":"Rodbard","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1331\/JAPhA.2014.13195_bb0035","doi-asserted-by":"crossref","first-page":"302.e1","DOI":"10.1016\/j.amjmed.2011.07.033","article-title":"Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications","volume":"125","author":"Desai","year":"2012","journal-title":"Am J Med"},{"issue":"2","key":"10.1331\/JAPhA.2014.13195_bb0040","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1590\/S0004-27302012000200005","article-title":"Prescription patterns for diabetes mellitus and therapeutic implications: a population-based analysis","volume":"56","author":"Guidoni","year":"2012","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"4","key":"10.1331\/JAPhA.2014.13195_bb0045","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1590\/S1415-790X2012000400013","article-title":"Polypharmacy among the elderly in the city of Sao Paolo, Brazil \u2013 SABE Study","volume":"15","author":"Carvalho","year":"2013","journal-title":"Rev Bras Epidemiol"},{"issue":"2","key":"10.1331\/JAPhA.2014.13195_bb0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.amjopharm.2012.02.003","article-title":"Polypharmacy with common diseases in hospitalized elderly patients","volume":"10","author":"Mizokami","year":"2012","journal-title":"Am J Geriatr Pharmacother"},{"issue":"3","key":"10.1331\/JAPhA.2014.13195_bb0055","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.diabres.2009.10.019","article-title":"Comorbidity in the elderly with diabetes: identification of areas of potential treatment conflicts","volume":"87","author":"Caughey","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"10.1331\/JAPhA.2014.13195_bb0060","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0895-4356(99)00055-4","article-title":"Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitus","volume":"52","author":"Glynn","year":"1999","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1331\/JAPhA.2014.13195_bb0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jdiacomp.2011.11.005","article-title":"Trends in insulin use among US adults with type 2 diabetes: the Behavioral Risk Factor Surveillance System 1995\u20132007","volume":"26","author":"Li","year":"2012","journal-title":"J Diabetes Complications"},{"key":"10.1331\/JAPhA.2014.13195_bb0070","first-page":"E110","article-title":"Construction of a multisite DataLink using electronic health records for the identification, surveillance, prevention, and management of diabetes mellitus: the SUPREME-DM project","volume":"9","author":"Nichols","year":"2012","journal-title":"Prev Chronic Dis"},{"key":"10.1331\/JAPhA.2014.13195_bb0075","unstructured":"AHFS Drug Information. AHFS Pharmacologic\u2013Therapeutic Classification System. www.ahfsdruginformation.com\/class. Accessed August 6, 2013."},{"key":"10.1331\/JAPhA.2014.13195_bb0080","series-title":"Microeconometrics using stata, revised edition","author":"Cameron","year":"2010"},{"issue":"23","key":"10.1331\/JAPhA.2014.13195_bb0085","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1001\/jama.1996.03540230036032","article-title":"Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension","volume":"276","author":"Curb","year":"1996","journal-title":"JAMA"},{"issue":"7160","key":"10.1331\/JAPhA.2014.13195_bb0090","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/bmj.317.7160.713","article-title":"Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"},{"issue":"7258","key":"10.1331\/JAPhA.2014.13195_bb0095","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bmj.321.7258.412","article-title":"Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study","volume":"321","author":"Adler","year":"2000","journal-title":"BMJ"},{"issue":"8934","key":"10.1331\/JAPhA.2014.13195_bb0100","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","journal-title":"Lancet"},{"issue":"20","key":"10.1331\/JAPhA.2014.13195_bb0105","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of the AFCAPS\/TexCAPS","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"issue":"15","key":"10.1331\/JAPhA.2014.13195_bb0110","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/01.CIR.97.15.1446","article-title":"Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial","volume":"97","author":"Sacks","year":"1998","journal-title":"Circulation"},{"key":"10.1331\/JAPhA.2014.13195_bb0115","doi-asserted-by":"crossref","first-page":"S11-S66","DOI":"10.2337\/dc13-S011","article-title":"Standards of medical care in diabetes\u20142013","volume":"36","author":"American Diabetes Association","year":"2013","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1331\/JAPhA.2014.13195_bb0120","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s11606-012-2320-1","article-title":"Independent contribution of A1C, systolic blood pressure, and LDL cholesterol to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study","volume":"28","author":"Nichols","year":"2013","journal-title":"J Gen Intern Med"},{"issue":"8","key":"10.1331\/JAPhA.2014.13195_bb0125","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2337\/dc11-0031","article-title":"Increased risk of myocardial infarction in depressed patients with type 2 diabetes","volume":"34","author":"Scherrer","year":"2011","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1331\/JAPhA.2014.13195_bb0130","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/diacare.25.3.464","article-title":"Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes","volume":"25","author":"Egede","year":"2002","journal-title":"Diabetes Care"},{"issue":"21","key":"10.1331\/JAPhA.2014.13195_bb0135","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1001\/archinte.160.21.3278","article-title":"Depression and diabetes: impact of depressive symptoms on adherence, function, and costs","volume":"160","author":"Ciechanowski","year":"2000","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1331\/JAPhA.2014.13195_bb0140","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.2337\/dc08-1341","article-title":"Depression and diabetes treatment nonadherence: a meta-analysis","volume":"31","author":"Gonz\u00e1lez","year":"2008","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1331\/JAPhA.2014.13195_bb0145","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.2337\/dc08-0985","article-title":"Depression and type 2 diabetes over the lifespan: a meta-analysis","volume":"31","author":"Mezuk","year":"2008","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1331\/JAPhA.2014.13195_bb0150","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2337\/diacare.24.6.1069","article-title":"The prevalence of comorbid depression in adults with diabetes: a meta-analysis","volume":"24","author":"Anderson","year":"2001","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1331\/JAPhA.2014.13195_bb0155","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0022-3999(02)00416-6","article-title":"Treatment of depression in diabetes: impact on mood and medical outcome","volume":"53","author":"Lustman","year":"2002","journal-title":"J Psychosom Res"},{"issue":"14","key":"10.1331\/JAPhA.2014.13195_bb0160","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1001\/jama.2010.1482","article-title":"Managing medications in clinically complex elders: \u201cThere's got to be a happy medium.\u201d","volume":"304","author":"Steinman","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"10.1331\/JAPhA.2014.13195_bb0165","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2337\/diaspect.15.4.240","article-title":"Polypharmacy in elderly patients with diabetes","volume":"15","author":"Good","year":"2002","journal-title":"Diabetes Spectrum"},{"key":"10.1331\/JAPhA.2014.13195_bb0170","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1745-6215-11-95","article-title":"Study protocol: The Adherence and Intensification of Medications (AIM) study\u2014a cluster randomized controlled effectiveness study","volume":"11","author":"Heisler","year":"2010","journal-title":"Trials"},{"issue":"23","key":"10.1331\/JAPhA.2014.13195_bb0175","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1161\/CIRCULATIONAHA.111.089169","article-title":"Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial","volume":"125","author":"Heisler","year":"2012","journal-title":"Circulation"},{"issue":"2","key":"10.1331\/JAPhA.2014.13195_bb0180","first-page":"63","article-title":"Racial and ethnic disparities in prescription coverage and medication use","volume":"25","author":"Briesacher","year":"2003","journal-title":"Health Care Financ Rev"},{"issue":"11","key":"10.1331\/JAPhA.2014.13195_bb0185","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/MLR.0b013e31826c85f9","article-title":"Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetes","volume":"50","author":"Stuart","year":"2012","journal-title":"Med Care"},{"key":"10.1331\/JAPhA.2014.13195_bb0190","doi-asserted-by":"crossref","first-page":"172423","DOI":"10.1155\/2012\/172423","article-title":"Changing trends in the prevalence and disparities of obesity and other cardiovascular disease risk factors in three racial\/ethnic groups of USA adults","volume":"2012","author":"Romero","year":"2012","journal-title":"Adv Prev Med"},{"issue":"1","key":"10.1331\/JAPhA.2014.13195_bb0195","first-page":"143","article-title":"Racial and ethnic differences in cardiovascular disease risk factors: a systematic review","volume":"17","author":"Kurian","year":"2007","journal-title":"Ethn Dis"},{"issue":"5","key":"10.1331\/JAPhA.2014.13195_bb0200","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s11606-008-0554-8","article-title":"Why don't diabetes patients achieve recommended risk factor levels? Poor adherence vs. lack of treatment intensification","volume":"23","author":"Schmittdiel","year":"2008","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1331\/JAPhA.2014.13195_bb0205","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11606-011-1829-z","article-title":"Characteristics of patients with primary non-adherence to medications for hypertension. diabetes, and lipid disorders","volume":"27","author":"Raebel","year":"2012","journal-title":"J Gen Intern Med"},{"issue":"24","key":"10.1331\/JAPhA.2014.13195_bb0210","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1056\/NEJMp0909327","article-title":"Primary care and accountable care: two essential elements of delivery system reform","volume":"361","author":"Rittenhouse","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1331\/JAPhA.2014.13195_bb0215","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11606-010-1289-x","article-title":"Developing a policy-relevant research agenda for the patient-centered medical home: a focus on outcomes","volume":"25","author":"Rittenhouse","year":"2010","journal-title":"J Gen Intern Med"},{"issue":"9","key":"10.1331\/JAPhA.2014.13195_bb0220","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/archinternmed.2012.872","article-title":"Achieving meaningful use of health information technology: a guide for physicians to the EHR incentive programs","volume":"172","author":"Marcotte","year":"2012","journal-title":"Arch Intern Med"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115302119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115302119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T00:27:01Z","timestamp":1538612821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319115302119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1544319115302119"],"URL":"https:\/\/doi.org\/10.1331\/japha.2014.13195","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}